Ideas catalog
Every idea we've derived from recent research — the ones marked “Prototype” come with a live demo you can try.
A conceptually valid but over-scoped platform idea resting on thin evidence, entering a market already crowded with well-funded incumbents and facing steep regulatory and EHR-integration hurdles that the pitch substantially underweights.
A high-concept application of cognitive psychology that lacks a clear commercial value proposition and relies on a single theoretical paper.
An incremental extension of existing EU tyre-label frameworks riding real regulatory tailwinds, but the idea is built on a single review paper that explicitly flags scientific gaps, faces dominant incumbent certification bodies, and depends on external actors to mandate the standard before it scales.
A technically straightforward SaaS wrapper around a published academic calculator that lacks defensible IP, targets an infrastructure that barely exists outside German pilots, and faces a market too small and dependent on third-party rollout to justify venture-scale ambition.
An over-scoped 'platform' idea that conflates high-friction hardware (EEG) with software onboarding, creating a product that is likely too intrusive for its target enterprise market.
Backed by 4 papers
A low-moat consulting service based on a generic journal description that lacks a proprietary technical edge or a scalable product mechanism.
A generic monitoring platform that lacks a specific technical wedge and relies on a broad policy report rather than a proprietary technical breakthrough.
A standards-aligned manufacturing software marketplace is a real need validated by solid EU research, but the idea is over-scoped, faces severe two-sided cold-start dynamics against entrenched incumbents (Siemens Xcelerator, PTC), and the ISA-95/RAMI 4.0 compliance wedge is more barrier than differentiator.
A vague, over-scoped wellness application that attempts to digitize complex psychotherapeutic principles without a concrete product mechanism.
A technically plausible but severely underdifferentiated fleet-safety analytics service entering a market already dominated by well-funded incumbents (Samsara, Lytx, Netradyne) with no clear wedge beyond replicating a published academic pipeline.
An intellectually coherent but commercially thin academic-utility tool built on a single, still-provisional research project, with no articulated monetization and a narrow Italian-language niche that limits investable scale.
The idea is a generic software wrapper for existing engineering workflows, lacking a specific technical breakthrough or a concrete evidence base beyond general journal descriptions.
Backed by 2 papers
A low-moat educational kit based on a decades-old theory that lacks a strong commercial wedge and faces significant implementation hurdles in classrooms.
A conceptually appealing behavioral-health screening idea that overreaches from a single narrative review to claimed validated culture-specific clinical thresholds, with no clear payer, confused go-to-market, and a technically demanding validation path the evidence cannot yet support.
A mechanistically interesting idea grounded in a single solid paper, but commercially thin due to an extremely rare target genotype, technically demanding 'partial inhibitor' requirement, and an over-scoped, multi-modal pitch that lacks a crisp go-to-market wedge.
A locally-calibrated parasite surveillance service for tropical aquaculture addresses a real food-safety and yield problem, but it rests on a single descriptive ecology study and faces serious go-to-market and AI-feasibility hurdles.
A socially ambitious concept that lacks a viable commercial mechanism, as it attempts to solve a systemic policy failure with a software layer without a clear regulatory or funding mandate.
A philosophically interesting but thinly evidenced governance artifact that stretches a single humanities text into an AI compliance product without a clear regulatory demand signal or technical operationalization path.
A low-moat utility tool that attempts to solve a fragmentation problem but faces insurmountable API and licensing barriers from proprietary database owners.
Technically credible productization of a single academic case study, but the architecture is now public knowledge, the market is narrow, and there is no clear moat or monetization mechanism beyond consultancy.